LakeShore Biopharma has commenced the submission of its biologics license applic...
A Phase III trial with the companies’ monoclonal antibody in patients with chron...
Advancing to first-in-human clinical trials requires formulation development to ...
Mustang Bio has received orphan drug designation from the US Food and Drug Admin...
Sonnet BioTherapeutics has announced the issuance of US Patent No. 12,134,635 co...
Demis Hassabis, joint winner of the Nobel Prize in Chemistry 2024, shared insigh...
The UWWTD will require manufacturers to fund micropollutant removal, but Zentiva...
The FDA-approved schizophrenia and bipolar disorder therapy met the primary and ...
The top 20 biopharmaceutical companies demonstrated signs of recovery during the...
Sales of the GLP-1RA hit $2.5bn in Q3, a 79% increase over the same period last ...
GSK CEO Emma Walmsley said the sector would need to wait to see who is appointed...
Tevogen Bio’s AI effort Tevogen.AI has partnered with Microsoft to advance the d...
Trump has not been vocal about healthcare policies but indicated that RFK Jr. wi...
Nxera Pharma has entered a collaboration and licensing agreement with Antiverse ...
The EMA has granted approval for Sanofi/Regeneron’s Dupixent (dupilumab) to trea...
In exchange for $285 million, Copenhagen-based Ascendis has agreed to help Novo ...
